Table 1.
Parameters | All patients (n = 85) | COVID-19 patients with ARDS (n = 42) | Non-COVID-19 patients with ARDS (n = 43) | P-value |
---|---|---|---|---|
Age (years) | 49.7 ± 0.93 | 49.5 ± 1.29 | 49.9 ± 1.36 | 0.84 |
Body Mass Index (kg/m2) | 25.2 ± 0.37 | 27.1 ± 0.41 | 23.3 ± 0.46 | 0.001* |
Sex (Male, %) | 63 (74.1%) | 33 (78.6%) | 30 (69.8%) | 0.22 |
Comorbidities, n (%) | ||||
None One Two or more |
43 (50.6%) 24 (28.2%) 18 (21.2%) |
22 (52.4%) 12 (28.6%) 8 (19.0%) |
21 (48.8%) 12 (27.9%) 10 (23.3%) |
0.64 0.92 0.51 |
Symptoms onset to ICU admission (days) | 7.24 ± 0.36 | 6.1 ± 0.28 | 8.3 ± 0.62 | 0.001* |
SOFA score (baseline) | 9.4 ± 0.23 | 9.7± 0.39 | 9.2 ± 0.22 | 0.29 |
APACHE II score, (baseline) | 22.3 ± 0.13 | 22.4 ± 0.19 | 22.2 ± 0.72 | 0.37 |
ARDS, acute respiratory distress syndrome; ICU, intensive care unit; APACHE II score, Acute Physiology and Chronic Health Evaluation II score; SOFA score, Sequential Organ Function Assessment score.
P-values ≤ 0.05 were statistically significant (comparisons between the COVID-19 vs. the non-COVID-19 group of patients).